Proteus Biomedical, Inc. Announces Issuance of U.S. Patent for Ingestible Digital Devices

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Proteus Biomedical Inc., a pioneer in intelligent medicine, announced today that the United States Patent Office awarded U.S. Patent Number 7,978,064 to Proteus. The patent, entitled “Communication System with Partial Power Source,” is directed to the Proteus ingestible event marker, a sensor and communication device at the heart of the Proteus Raisin™ System.

MORE ON THIS TOPIC